This paper is dedicated to Professor George R. Waller for his 80 th birthday.
Firefly luciferase is a euglobulin [5] . The active enzyme from Photinus pyralis (the common North American firefly) has a molecular weight of 1.2 x 10 5 Da, is comprised of two identical subunits (61 x 10 3 Da), and has a pH optimum of 7.8 and a temperature optimum of 25˚C.
The published characterizations suggest binding of two luciferins, one MgATP, two ATPs, and one luciferyl adenylate.
Luciferase contains two -SH groups that influence active site conformation but are not required for activity. Firefly luciferase is extremely hydrophobic; the monomer is apparently active, but the enzyme exists as a dimer in most solutions [6] . Luciferase has an anion-binding site and is inhibited by AMP, ATP, PP i , and some other anions. There is a large conformational change during firefly luciferase catalysis, specifically a change from 37% to 14% helix upon addition of substrates [7] . In the presence of substrates, 300 hydrogens become "nonexchangeable" as measured by 3 H-1 H exchange; i.e., some regions of the protein became completely inaccessible to water (an estimated 40% of the enzyme).
Leach with N-[1-
14 C]-ethylmaleimide. Trypsin treatment and chromatography of the resulting peptides resulted in the isolation of a radioactive decapeptide fragment. The amino acid sequence of the peptide was S-*C-E-G-N-A-G-S-Q-K (labeled residues shown by *). A peptide from the presumed luciferin binding site was isolated by Lee and McElroy [9] . 2-Cyano-6-chlorobezo-thiazole slowly inactivated firefly luciferase with the incorporation of between 1.5 and 2 mol of reactant per mol of enzyme. Trypsin digestion yielded a fluorescent peptide that was isolated by electrophoresis. The sequence of the peptide was pyroglu-(Y?)-G-A-V-(D)-I-L.
5'[p-(Fluorosulfonyl)-benzoyl] adenosine (FSBA) was used to label a K near the putative ATP binding site [10] . The amino acid sequence around the labeled K is *K-G-(E or Q)-(D or N)-S-K. MgATP blocked the inactivation of firefly luciferase by FSBA. When the cloned mRNA's corresponding amino acid sequence was compared with those three peptide sequences, none were found present in the determined sequence [11] .
The -SH story. Two different -SH-containing sequences have now been labeled with [ 14 C]-Nethylmaleimide [12] . They are T-A-*C-V-R and G-E-L-*C-V-R with the Cs being amino acid residues 216 and 391, respectively, in the sequence derived from the cloned P. pyralis gene. The -SH groups in the above peptides are protected from modification by either dehydroluciferyl adenylate or dehydroluciferin (substrate or intermediate analogs). Modification of these residues by most -SH-reactive reagents results in complete loss of enzymatic activity, but modification by methyl methanethiosulfonate produced an enzyme that emitted red light rather than the normal yellow-green light. The enzyme thus modified was catalytically active, but contained a distorted active site that operated by a different mechanism. Alter and DeLuca [12] concluded that these two -SH groups are not essential for activity, but have a role in determining the color of the light produced. Vellom [13] substituted alanine individually for each of those two C residues and catalytic activity was retained, proving that they were not required for the reaction. Kutuzova and Baldwin [14] modified the corresponding C residues in Luciola mingrelica firefly luciferase by mutagenesis and showed that the resultant proteins were fully active. Kumita et al. [15] changed all four cysteine residues of firefly luciferase to serine and the resulting enzyme retained about 10 % of wild-type activity. Chemical modification -recent studies. An active site peptide at or near the luciferin binding site was identified by Branchini and colleagues using a benzophenone-based photooxidation reagent [16] , The peptide labeled was the 244 HHG 247 F sequence and firefly luciferase activity was inhibited. Table 1 summarizes the results of extensive chemical modification studies done in my laboratory.
Thiourea dioxide modification. Thiourea dioxide inactivation of firefly luciferase was time-and concentration-dependent. Regardless of the ATP concentration (high or low) used for measuring light production, 50% inhibition was produced by 50 mM thiourea dioxide when the reagent was incubated with luciferase for 30 min.
Radioactive thiourea dioxide was used to identify the modified amino acid residue. About 80% inhibition of firefly luciferase activity was achieved during a 30-min incubation with 50 mM thiourea dioxide and 97% inhibition was reached with 100-min incubations. There were 1.3 and 2.3 moles of radioactive thiourea dioxide incorporated per mole of firefly luciferase, respectively. The inclusion of ATP in the incubation mixture reduced the inhibition of enzyme activity and the incorporation of radioactive thiourea dioxide. With a 2 h-incubation 2.4 moles of thiourea dioxide were incorporated in the control incubation whereas only 1.4 moles were incorporated when 100 mM ATP was present.
Tryptic peptides were produced, isolated, and sequenced. The peptide with the 30 min retention time was GLTGK (K-529) and the peptide with a
Firefly Luciferase
Natural Product Communications Vol. 3 (9) 2008 1439 59 min retention time had a SGYVNNPEATNALI sequence (K414 next in sequence). When ATP is present to prevent labeling of the presumed active site, the peak with the 30 min retention time was not labeled; this suggests that this lysine, K529, might be involved in the enzymatic reaction.
Fluorescein
5'-isothiocyanate modification.
Fluorescein 5'-isothiocyanate (FITC) is a lysinespecific affinity probe with a structural similarity to ATP.
There was a time-and concentrationdependent inactivation of firefly luciferase. Using absorbance at 495 nm to determine the number of FITC molecules reacting per molecule of firefly luciferase, the incorporation of one molecule resulted in approximately 50% inhibition. The corresponding sample that had been protected with ATP contained 0.6 molecule of FITC per molecule of luciferase.
Firefly luciferase was inactivated by incubation with FITC in the presence and absence of ATP. Tryptic peptide samples were prepared; then the peptides were separated by HPLC. The major fluorescent peak eluted at ~64 min for both protected and unprotected samples (the fluorescence was much stronger in the unprotected sample). This fraction was subjected to amino acid sequencing. In the unprotected sample, two major components GPMIMSGYVNNPEATNALI (P. pyralis residues 394-412) and QGYGLTETTSAILITPEGD (residues 338-356) and a minor component TIALIMNSSGSTGLPK (residues 191-206) were found. In the ATP-protected sample only the two major components were found.
The GLTGK sequence, eluting ~30 min in the thiourea dioxidelabeled samples, was not labeled in either sample. A peptide containing K 206 was present. The IMNSSGSTGLPK sequence is consistent with the established AMP-binding domain signature sequence.
Arginine modification. Phenylglyoxal is used to modify arginine residues in proteins. The original reaction mechanism proposed by Takahashi involved the reaction of two phenylglyoxal molecules per reactive arginine residue [18] . The phenylglyoxal reacts with the guanido group of arginine under mild conditions of pH, 7-8, and 25º C. This 2:1 reaction stoichiometry has been found for most proteins [19, 20] .
The conserved R residues from a comparison of 161 firefly luciferase sequences correspond to positions 437 and 513 in P. pyralis. Phenylglyoxal treatment Tryptic peptides derived from firefly luciferase that had been modified with phenylglyoxal were analyzed by HPLC and mass spectrometry. The position 512-524 peptide containing R 513 was identified with a doubly-modified R. The modification also occurred approximately equally in the presence or absence of ATP. This indicates that this residue is probably not involved in enzymatic activity.
From the crystallographic structure of firefly luciferase this residue is located on the exterior of the protein and away from the presumed active site.
Peptide 394-439 (the 414-415 K-D bond is hard for trypsin to cleave) which contains R 437 was found with a mass corresponding to a single phenylglyoxal modified arginine. Two charge forms of this singly modified peptide were observed: 3+ and 4+ that eluted from the chromatographic column at ~29 min. There is a low amount of this peptide in the firefly luciferase sample that has been protected with ATP. This result complements the enzymatic activity inactivation results and is consistent with this residue being at the active site. A search for other either singly or doubly labeled modified arginine residues produced no such modified residues.
Amino acids identified by mutagenesis studies.
The Table 2 summarizes these results.
Cloning/ conserved amino acids mRNA cloned. The mRNA for firefly luciferase from Photinus pyralis has been cloned and the cDNA nucleotides sequenced [28] . The sequences of some 161 different firefly luciferases are now available from the GenBank, the protein databases, original publications, and patent applications. These have been compared via multialignment programs and are shown in Table 3 .
The conservation of amino acids in the firefly luciferases for given regions can be easily visualized used the WebLogo program [29] to create sequence logos (see Figure 1 ).
3-D crystallographic structure/active site
Determined without additions. Conti, Franks, and Brick analyzed the structure of firefly luciferase, without any added compounds (substrates or products) being bound [30] . Firefly luciferase (pdb entry 1LCI) has a large N-terminal region of 436 amino acid residues with two β-sheet subdomains (A & B each has 8 strands), the A domain has 5 parallel strands, and the B domain has 6 parallel strands) that form a five-layered αβαβα structure and a distorted β-barrel (6 strands). Two α-helices are between the sheets and the other α-helices are on the faces; there 15 α-helices. The C-terminal domain has a 3-and a 2-strand antiparallel β-sheet (D and E) and three α-helices (a+b structure). There are 4 loops in the complete structure.
Determined with bromoform bound. The structure of another conformation of firefly luciferase, the socalled "low-ATP form", comes from the determination of the 3-D structure of firefly luciferase complexed with two molecules of bromoform (there are no nucleotides bound in the structure, pdb entry 1BA3) [31] . High concentrations of ATP yield a conformation of firefly luciferase with enhanced anesthetic binding capability [32] . In the "low-ATP form" there is little disturbance of the structure as the two bromoforms bind. One is bound in the luciferin pocket that is amphilic in nature. G191  S198  F220  N106  F163  K68  T190  S198  T184  S198  S193  S201  F223  Y109  G165  G71  K198  K206  F229  F243  N235  G246  T320  S198  I196  L133  F234  F243  Y231  G246  Y236  F247  K328  K206  V310  H244  D235  H244  W234  M249  A277  L286  G364  P242  V333  M265  N321  Q338  G302  G316  G306  G315  W365  F243  A357  V288  A322  G339  A304  P318  G307  G316  I366  H244  V386  G315  Y323  Y340  Q322  Q338  F330  Y340  V442  G315  T412  Y340  E327  E344  G323  G339  E334  E344  E444  G317  W413  G341  P347  A361  Y324  Y340  Q353  A361  P445  P318  Q415  L342  Y386  Y401  T327  T343  G354  V362  D467  Q338  T416  T343  K396  L411  E328  E344  D413  D422  T468  G339  E417  E344  Y409  L418  T357  A361  V425  I434  Y469  Y340  I512  H432  D413  D422  D418  D422  R428  R437  W470  T343  R515  R437  Y425  I434  I430  I434  K519  K529  T472  T345  D517  K439  R428  R437  R433  R437  S474  S347  S523  K445  K517  K529  K435  K439  R575  R437  G524  G446  K439  K443  V576  L438  H525  Y447  W444  Q448  D577  K439  R526  Q448  R672 L530 ttlcfacs = Thermus thermophilus long chain fatty acyl-CoA synthetase, pdb 1V25 [35] ; dhbe = Bacillus subtilis dihydroxybenzoate-AMP ligase, pdb 1MDB (72); yeastttacs = Saccharomyces cerevisiae acetyl-CoA synthetase, pdb 1RY2 [36] ; salmonellaacs = Salmonella enterica acetyl-CoA synthetase, pdb 1PG4 [37] ; Fadamu = Brevibacillus brevis phenylalanine activating domain of gramicidin synthetase 1, pdb 1AMU [34] ; and -gap in alignment. FL is the Phonitus pyralis firefly luciferase sequence with numbering corresponding to the aligned sequences from the other family members. Structures of similar proteins. The structure of another member of this superfamily of enzymes, the phenylalanine A subunit of the gramicidin S nonribosomal biosynthetic system, has been determined with ATP and phenylalanine bound (pdb entry 1AMU) [34] . The smaller C-terminal domain is rotated 94˙ relative to the N-terminal domain. This is presumably the active conformation. In the rotated C-domain, K517 (equivalent to K529 in firefly luciferase) is in a position to form electrostatic bonds with both the ATP and phenylalanine substrates; D413 (D422 in firefly luciferase) interacts with the ribose hydroxyls via hydrogen bonds.
Leach
The 3-D structure of the long-chain fatty acyl-CoA synthetase from Thermus thermophilus has been determined with either an ATP analogue (pdb 1V25) or myristoyl-AMP (pdb 1V26) bound [35] . The structure for yeast acetyl-CoA synthetase complexed with AMP (pdb 1RY2) has been determined by Jogi and Tong [36] . They observed that a rotation of the small C-terminal domain by 140˙ was needed to bind CoA and for the catalysis of the second step in the reaction. The enzyme functions as a trimer in yeast and as a monomer in bacteria. Salmonella enterica was the source for the bacterial acetyl-CoA synthetase whose structure was determined with bound adenosine 5-propylphosphtate and CoA bound (pdb 1PG4). This enzyme contains 652 amino acid residues [37] . CoA was required for the crystallization suggesting that CoA is required for the enzyme to assume the conformation observed. These authors suggest that two different conformations are required for the different steps in the reaction sequence.
The 2,3-dihydroxybenzoate activating enzyme (DhbE) catalyzes the first step in the non-ribosomal peptide synthesis of bacillibactin. The A domain of this synthetase is a stand-alone adenylation domain that activates 2,3-dihydroxybenzoate; this 59.9-kDa protein has a large N-terminal part and a smaller Cterminal domain like other members of the acyladenylate/thioester-forming enzyme superfamily. The 3-D structure has been determined by May and colleagues [38] . This enzyme apparently does not undergo the large reorientation of the two domains that other members of the group do; the authors observed only local structural rearrangements. The structure was determined with no substrates (pdb 1MDF) and with Dhb-adenylate bound (pdb 1MDB) or AMP and Dhb bound (pdb 1MD9). R428 which is equivalent to R437 of firefly luciferase forms a salt bridge with the α-phosphate, is strictly conserved, and is required for activity as shown by site-specific mutagenesis studies of 4-coumarate:CoA ligase [39] . The P-loop is located at the entrance to the catalytic cavity. K519 incorrectly shown as K517) interacts with the adenine moiety and is equivalent to K529 of firefly luciferase.
Postulated active site
The P-loop includes 200 There are two R residues that are conserved in the 161 firefly luciferase sequences: R437, and R513. R218 presumably functions in the stabilization of the luciferin phenolate [40] ; it is within about 6 Å of the oxygen of oxyluciferin. A search for the possible nonconserved R yielded no such modifications by phenylglyoxal.
I will now review the amino acid residues of adenylate-forming enzymes that are involved in the interaction with MgATP substrate. Since the members of this enzyme family probably involve similar mechanisms of action, a comparison of the amino acid residues proposed to be at their active The numbering of the amino acid residues is for Photinus pyralis. Those residues that interact with the adenine moiety include S338 and G339; those that interact with the ribose portion include S420, D422, and R437; and those that interact with the phosphate include S198, S199, H245, T343, E344, T527, and K529 sites from crystallographic studies might suggest other amino acid residues that might be involved in the enzymatic mechanism of firefly luciferase. Table  5 shows such a comparison for the long chain fatty acyl-CoA synthetases, the dihydroxybenzoate-AMP ligase, the yeast acetyl-CoA synthetases, the Salmonella acetyl-CoA synthetases, and the phenylalanine activating domain of gramicidin synthetase. Those residues that interact with the phosphates include S/T with 15 occurrences, R with 14, D/E with 8, and K with 8. These observations provide suggestions of those amino acids residues that might be involved interaction with the ATP/AMP moieties in firefly luciferase.
The amino acids in this family of enzymes are correlated with analogous amino acids in firefly luciferase as shown in Table 6 .
R437 was found in all of the presumed active sites. This residue is the one labeled by phenylglyoxal in my laboratory and was not previously postulated to be at the firefly luciferase active site. The occurrence of this arginine residue in each of the family members strengthens our contention that R437 may be at the active site of firefly luciferase. The R449Q mutation of the 4-coumarate:CoA ligase protein that is equivalent to R437 in firefly luciferase markedly reduces enzymatic activity [39] .
The K540N mutation similarly decreased enzymatic activity and this lysine is equivalent to K529 in firefly luciferase that has an essential role. The R453A mutation in Leach Escherichia coli fatty acyl-CoA synthetase markedly decreased the enzymatic activity; this arginine corresponds to R437 of firefly luciferase [48] . In the 3-D structures of the adenylate-forming enzymes the arginines equivalent to the firefly luciferase R437 are four times involved in interactions with the α-phosphate and once with the ribose of the AMP structure.
A recent study for the Hecht group [49] shows that modification of R218 reduced light production and shifted the wavelength of light produced. They suggest that modification of R437 influences only the structure of firefly luciferase and is not close to a binding site. The crystallographic data they used was 1LCI which had no substrate, intermediate, nor product bound and that region of the protein is not present in the published 1LCI structure.
Amino acid residues suggested to be at the active sites of firefly luciferase for the many models of the active site are summarized in Table 7 . Some of these residues are replaced by other amino acids in the various firefly luciferases of the 161 different sequences and this is shown in the fourth column.
Given the extensive information available concerning the amino acid residues of firefly luciferase from chemical modification, mutagenesis, and X-ray crystallography evidence the following Table 8 presents those that I consider very probable at the active site(s). Figure2 show these amino acids with the activated intermediate analog. The W417 whose chemical modification inhibits firefly luciferase activity is too distant in the crystallographic structure to be involved at the active site and it is left out; it must serve an essential structural function for the protein. The K206 may interact with the γ-phosphate's oxygens of ATP; but this cannot be determined because only AMP is shown in the crystallographic structure. K529 probably interacts with an oxygen of the α-phosphate of the ATP(AMP). It is suggested that a Y may be involved in the oxidation process involving molecular oxygen, but it is unclear which Y is involved. There are two ATP-binding sites based on enzymatic characterization and binding studies with firefly luciferase and the position of only one ATP is known from the crystallographic pattern.
